Wang G., Mudgal P., Wang L., Shuen T.W.H., Wu H., Alexander P.B., Wang W.W., Wan Y., Toh H.C.*, Wang X.-F.*, and Li Q.-J.* (2021) TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma. Oncoimmunology. 10(1):1955545. (*: Corresponding authors, PMCID: PMC8331028)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331028/